Lead, Medical Sciences and Outreach/Senior Science Fellow, Monsanto
St. Louis, Missouri
Daniel Goldstein received a BS (Molecular Biology) from University of Wisconsin (1976) and an MD from Johns Hopkins (1981), followed by residency in Pediatrics (Johns Hopkins) and fellowship in Clinical Pharmacology and Medical Toxicology (University of Toronto). He is board certified by the American Boards of Pediatrics, Medical Toxicology, and Clinical Pharmacology, and by the Royal College of Physicians of Canada (Pediatrics). He is a fellow of the American Academy of Pediatrics and American College of Medical Toxicology (ACMT, Board of Directors 2006-2009). Following 10 years in private practice in Denver, he joined Monsanto in 1998, was appointed Senior Science Fellow in 2002, and currently serves as Lead- Medical Sciences and Outreach, Monsanto Regulatory Affairs. He is involved in plant biotechnology, pesticide, and children’s health issues, and has served on the EPA Child Health Protection Advisory Committee and Science Advisory Board (early-life exposure to carcinogens), as an advisor to the NAFTA Commission for Environmental Cooperation (child health indicators). He participates in the National Conversation as a member of the Leadership Council and Monitoring Work Group (chair, Chemical Use and Exposure Pathways Sub-group).
Statement of Interest:
I am a Pediatrician, Medical Toxicologist, and Clinical Pharmacologist. Following a decade of private clinical practice and consulting, I joined Monsanto 11 years ago, and currently serve as Lead, Medical Sciences and Outreach within global Regulatory Affairs, and work externally via CropLife and American Chemistry Council. I have a longstanding interest in chemicals in the environment, particularly in the areas of biomonitoring, children's health, and the application of epidemiological data to chemical regulatory processes. Over the past decade, I have been fortunate to participate in dialogs such as the Child Health FACA and the NAFTA Council for Environmental Cooperation effort on child health metrics, which bring together a diversity of opinions. My experience has been that open dialog can lead to sometimes surprising discoveries of common interest and thereby illuminate paths forward. I look forward to the National Conversation as a next step in moving discussion forward in the important area of chemistry and public health.
Past exposures 4/5/10 10:01 AM
Concerns with the vision 4/5/10 9:56 AM
Greetings! 4/5/10 9:14 AM